379 related articles for article (PubMed ID: 26033707)
21. A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer.
Li J; Wang Y; Yu J; Dong R; Qiu H
Tumour Biol; 2015 Mar; 36(3):1661-5. PubMed ID: 25366139
[TBL] [Abstract][Full Text] [Related]
22. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients.
Tang S; Zheng K; Tang Y; Li Z; Zou T; Liu D
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180050
[TBL] [Abstract][Full Text] [Related]
24. Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population.
Bayram S; Sümbül AT; Batmacı CY; Genç A
Tumour Biol; 2015 May; 36(5):3863-70. PubMed ID: 25586347
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT
Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331
[TBL] [Abstract][Full Text] [Related]
26. Does HOTAIR expression level in the peripheral blood have veritably predictive/prognostic impact on breast cancer patients?
Ezzatizadeh V; Mozdarani H
J Transl Med; 2019 Dec; 17(1):404. PubMed ID: 31796041
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic roles of HOX transcript antisense intergenic RNA in cancer.
Fu CJ; Cong J; Sun SS; Ren MM; Xie SY; Wang PY
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e3-e9. PubMed ID: 32030884
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population.
Hassanzarei S; Hashemi M; Sattarifard H; Hashemi SM; Bahari G; Ghavami S
Tumour Biol; 2017 Oct; 39(10):1010428317727539. PubMed ID: 29022495
[TBL] [Abstract][Full Text] [Related]
29. Gene Expression of the Circulating Long Noncoding RNA
Ismail DM; Shaker OG; Kandeil MA; Hussein RM
Genet Test Mol Biomarkers; 2019 Sep; 23(9):671-680. PubMed ID: 31433231
[No Abstract] [Full Text] [Related]
30. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
[TBL] [Abstract][Full Text] [Related]
31. Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value.
Zhao WH; Yuan HY; Ren XY; Huang K; Guo ZY
Adv Clin Exp Med; 2019 Sep; 28(9):1179-1183. PubMed ID: 31414734
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract][Full Text] [Related]
33. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
[TBL] [Abstract][Full Text] [Related]
34. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
35. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
36. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
38. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
39. Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non-Small Cell Lung Cancer.
Li N; Wang Y; Liu X; Luo P; Jing W; Zhu M; Tu J
Technol Cancer Res Treat; 2017 Dec; 16(6):1060-1066. PubMed ID: 28784052
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2/HER2 positivity in breast cancer.
Wang YL; Liu LC; Hung Y; Chen CJ; Lin YZ; Wu WR; Wang SC
Breast; 2019 Aug; 46():64-69. PubMed ID: 31100572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
